South Dakota Investment Council Vanda Pharmaceuticals Inc. Transaction History

South Dakota Investment Council

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$15.71 - $21.51 $348,762 - $477,522	-22,200 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$12.38 - $17.47 $102,754 - $145,001	8,300 Added 59.71%	22,200 $364,000
Q3 2019 Nov 13, 2019	BUY	$12.27 - $15.79 $92,025 - $118,425	7,500 Added 117.19%	13,900 $185,000
Q4 2018 Feb 06, 2019	BUY	$18.97 - $31.47 $121,408 - $201,408	6,400 New	6,400 $167,000

156

45.1M

136K

220K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $264M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

Stay updated on South Dakota Investment Council with notifications on news.